Exact Mass: 366.1857794
Exact Mass Matches: 366.1857794
Found 500 metabolites which its exact mass value is equals to given mass value 366.1857794,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
dehydrocorydalin
C22H24NO4+ (366.17052440000003)
Dehydrocorydaline is an alkaloid. Dehydrocorydaline is a natural product found in Corydalis turtschaninovii, Corydalis nobilis, and other organisms with data available. Dehydrocorydaline (13-Methylpalmatine) is an alkaloid that regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP[1]. Dehydrocorydaline elevates p38 MAPK activation. Anti-inflammatory and anti-cancer activities[2]. Dehydrocorydaline shows strong anti-malarial effects (IC50=38 nM), and low cytotoxicity (cell viability?>?90\\%) using P. falciparum 3D7 strain[3]. Dehydrocorydaline (13-Methylpalmatine) is an alkaloid that regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP[1]. Dehydrocorydaline elevates p38 MAPK activation. Anti-inflammatory and anti-cancer activities[2]. Dehydrocorydaline shows strong anti-malarial effects (IC50=38 nM), and low cytotoxicity (cell viability?>?90\%) using P. falciparum 3D7 strain[3].
Hirsuteine
C22H26N2O3 (366.19433260000005)
Corynantheine is a monoterpenoid indole alkaloid. Corynantheine is a natural product found in Corynanthe pachyceras, Uncaria rhynchophylla, and other organisms with data available. Hirsuteine is an alkaloid. Hirsuteine is a natural product found in Uncaria tomentosa, Mitragyna hirsuta, and other organisms with data available. See also: Cats Claw (part of). Annotation level-1 Hirsuteine is an indole alkaloid extracted from Uncaria rhynchophylla. Hirsuteine non-competitively antagonizes nicotine-mediated dopamine release by blocking ion permeation through nicotinic receptor channel complexes[1].
Diacetoxyscirpenol
Diacetoxyscirpenol is a constituent of Fusarium species Mycotoxin D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins Constituent of Fusarium subspecies Mycotoxin C784 - Protein Synthesis Inhibitor D000970 - Antineoplastic Agents
20-Carboxy-leukotriene B4
20-Carboxyleukotriene B4 is an omega-oxidized metabolite of leukotriene B4 (LTB4). Neutrophil microsomes are known to oxidize 20-hydroxy-LTB4 (20-OH-LTB4) to its 20-oxo and 20-carboxy derivatives in the presence of NADPH. This activity has been ascribed to LTB4 omega-hydroxylase (cytochrome P-450LTB omega). Leukotriene B4 release from polymorphonuclear granulocytes of severely burned patients was reduced as compared to healthy donor cells. This decrease is due to an enhanced conversion of LTB4 into the 20-hydroxy- and 20-carboxy-metabolites and further to a decreased LTB4-synthesis. LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. Other specific pathways of leukotriene metabolism include the 12-hydroxydehydrogenase/ 15-oxo-prostaglandin-13-reductase that form a series of conjugated diene metabolites that have been observed to be excreted into human urine. Metabolism of LTC4 occurs by sequential peptide cleavage reactions involving a gamma-glutamyl transpeptidase that forms LTD4 (leukotriene D4) and a membrane-bound dipeptidase that converts LTD4 into LTE4 (leukotriene E4) before w-oxidation. These metabolic transformations of the primary leukotrienes are critical for termination of their biological activity, and defects in expression of participating enzymes may be involved in specific genetic disease. (PMID 17623009, 7633595, 2155225, 3039534)Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways.
2,2-Dimethyl-3-(4-methoxyphenyl)-4-propyl-2H-1-benzopyran-7-ol acetate
6alpha,9-Difluoro-11beta-hydroxyprogesterone
C21H28F2O3 (366.20064019999995)
Fortimicin KK1
An amino cyclitol glycoside that is (1R,2S,3S,4S,5S,6R)-2-amino-1,3,4,6-tetrahydroxy-5-(methylamino)cyclohexane in which the hydroxy group at position 1 is glycosylated by a heptapyranosyl residue.
17-(Trifluorovinyl)-3-(methyl ether)-17beta-estradiol
C21H25F3O2 (366.18065459999997)
Rilpivirine
Rilpivirine belongs to the class of organic compounds known as nitrotoluenes. These are organic aromatic compounds containing a benzene that carries a single methyl group and at least 1 nitro group. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AG - Non-nucleoside reverse transcriptase inhibitors C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent
Anhydrocinnzeylanol
Anhydrocinnzeylanol is found in chinese cinnamon. Anhydrocinnzeylanol is isolated from Cinnamomum cassia (Chinese cinnamon). Isolated from Cinnamomum cassia (Chinese cinnamon). Anhydrocinnzeylanol is found in chinese cinnamon and herbs and spices.
4-Acetyl-2-prenylphenol glucoside
4-Acetyl-2-prenylphenol glucoside is found in herbs and spices. 4-Acetyl-2-prenylphenol glucoside is a constituent of Helichrysum italicum (curry plant). Constituent of Helichrysum italicum (curry plant). 4-Acetyl-2-prenylphenol glucoside is found in tea and herbs and spices.
Sporotrichiol
Sporotrichiol is produced by Fusarium sporotrichioides. Production by Fusarium sporotrichioides
(1S,2S,4R,8S)-p-Menthane-1,2,8,9-tetrol 2-glucoside
(1S,2S,4R,8S)-p-Menthane-1,2,8,9-tetrol 2-glucoside is found in fats and oils. (1S,2S,4R,8S)-p-Menthane-1,2,8,9-tetrol 2-glucoside is a constituent of fruit of Carum carvi (caraway). Constituent of fruit of Carum carvi (caraway). (1S,2S,4R,8R)-p-Menthane-1,2,8,9-tetrol 2-glucoside is found in fats and oils and herbs and spices.
(1R*,2R*,4R*,8S*)-p-Menthane-1,2,8,9-tetrol 9-glucoside
(1R*,2R*,4R*,8S*)-p-Menthane-1,2,8,9-tetrol 9-glucoside is found in fats and oils. (1R*,2R*,4R*,8S*)-p-Menthane-1,2,8,9-tetrol 9-glucoside is a constituent of fruit of Carum carvi (caraway). Constituent of fruit of Carum carvi (caraway). (1R*,2R*,4R*,8S*)-p-Menthane-1,2,8,9-tetrol 9-glucoside is found in fats and oils and herbs and spices.
Bufotenine O-glucoside
Bufotenine O-glucoside is found in citrus. Bufotenine O-glucoside is an alkaloid from the leaves of Citrus unshiu (satsuma mandarin
Secoeremopetasitolide A
Secoeremopetasitolide A is found in green vegetables. Secoeremopetasitolide A is a constituent of Petasites japonicus (sweet coltsfoot). Constituent of Petasites japonicus (sweet coltsfoot). Secoeremopetasitolide A is found in green vegetables.
(2R,6x)-7-Methyl-3-methylene-1,2,6,7-octanetetrol 2-glucoside
(2R,6x)-7-Methyl-3-methylene-1,2,6,7-octanetetrol 2-glucoside is found in herbs and spices. (2R,6x)-7-Methyl-3-methylene-1,2,6,7-octanetetrol 2-glucoside is a constituent of Foeniculum vulgare (fennel). Constituent of Foeniculum vulgare (fennel). (2R,6x)-7-Methyl-3-methylene-1,2,6,7-octanetetrol 2-glucoside is found in herbs and spices.
12-oxo-10,11-dihydro-20-COOH-LTB4
12-oxo-10,11-dihydro-20-COOH-LTB4 is formed when leukotriene B4 (LTB4) is metabolized by beta-oxidation. LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. (PMID: 8632343, 9667737). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 12-oxo-10,11-dihydro-20-COOH-LTB4 is formed when leukotriene B4 (LTB4) is metabolized by beta-oxidation. LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. (PMID: 8632343, 9667737)
12-oxo-20-dihydroxy-leukotriene B4
12-oxo-20-dihydroxy-leukotriene B4 is the metabolite of lipid omega-oxidation of leukotriene B4 (LTB4). LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region, and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by omega-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the omega-carboxy position and after CoA ester formation (PMID: 7649996, 17623009, 2853166, 6088485). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 12-oxo-20-dihydroxy-leukotriene B4 is the metabolite of lipid omega-oxidation of leukotriene B4 (LTB4). LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. (PMID: 7649996, 17623009, 2853166, 6088485)
1-[(1R,2R,3S,4S)-3-Hydroxy-4,7,7-trimethyl-2-bicyclo[2.2.1]heptanyl]-3-(4-methylphenyl)sulfonylurea
C18H26N2O4S (366.16131960000007)
7-Oxoprostaglandin I2
Corynantheine
C22H26N2O3 (366.19433260000005)
(E)-4-(4-(4-(2-Cyanovinyl)-2,6-dimethylphenylamino)pyrimidin-2-ylamino)benzonitrile
Geissoschizine methyl ether
C22H26N2O3 (366.19433260000005)
Gosogliptin
5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine
Linaprazan
C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29723 - Proton Pump Inhibitor
1-[2-[4-Methoxy-3-[3-(4-methoxyphenyl)propoxy]phenyl]ethyl]imidazole
C22H26N2O3 (366.19433260000005)
N,N-Diethyl-2-(2-(4-methoxyphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide
Acetamide, 2-((2-hydroxyethyl)thio)-N-(3-(3-(1-piperidinylmethyl)phenoxy)propyl)-
C19H30N2O3S (366.19770300000005)
1-[2-[4-Methoxy-2-[3-(4-methoxyphenyl)propoxy]phenyl]ethyl]imidazole
C22H26N2O3 (366.19433260000005)
Britannin
Britannin, isolated from Inula aucheriana, is a sesquiterpene lactone. Britannin induces apoptosis and autophagy by activating AMPK regulated by ROS in liver cancer cells. Britannin has anti-proliferative and anti-inflammatory activities[1][2][3]. Britannin, isolated from Inula aucheriana, is a sesquiterpene lactone. Britannin induces apoptosis and autophagy by activating AMPK regulated by ROS in liver cancer cells. Britannin has anti-proliferative and anti-inflammatory activities[1][2][3].
Geissoschizine_methyl_ether
C22H26N2O3 (366.19433260000005)
Geissoschizine methyl ether is a natural product found in Uncaria rhynchophylla and Uncaria sinensis with data available. Geissoschizine methyl ether, a major indole alkaloid found in Uncaria hook, is a major active component of Yokukansan with psychotropic effects. Geissoschizine methyl ether is potent 5-HT1A receptor agonist[1][2]. Geissoschizine methyl ether, a major indole alkaloid found in Uncaria hook, is a major active component of Yokukansan with psychotropic effects. Geissoschizine methyl ether is potent 5-HT1A receptor agonist[1][2]. Geissoschizine methyl ether, a major indole alkaloid found in Uncaria hook, is a major active component of Yokukansan with psychotropic effects. Geissoschizine methyl ether is potent 5-HT1A receptor agonist[1][2].
Voachalotine
C22H26N2O3 (366.19433260000005)
A monoterpenoid indole alkaloid with formula C22H26N2O3, isolated from several Tabernaemontana species.
19,20-Didehydro-10-methoxytalcarpine
C22H26N2O3 (366.19433260000005)
3-Geranyl-2,4,6-trihydroxybenzophenone
A member of the class of benzophenones that is benzophenone substituted by a geranyl group at position 3 and hydroxy groups at positions 2, 4 and 6 respectively. Isolated from Leontonyx and Garcinia vieillardii, it exhibits a significant antileishmanial activity.
Dehydrocorydaline
C22H24NO4+ (366.17052440000003)
Dehydrocorydaline (13-Methylpalmatine) is an alkaloid that regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP[1]. Dehydrocorydaline elevates p38 MAPK activation. Anti-inflammatory and anti-cancer activities[2]. Dehydrocorydaline shows strong anti-malarial effects (IC50=38 nM), and low cytotoxicity (cell viability?>?90\\%) using P. falciparum 3D7 strain[3]. Dehydrocorydaline (13-Methylpalmatine) is an alkaloid that regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP[1]. Dehydrocorydaline elevates p38 MAPK activation. Anti-inflammatory and anti-cancer activities[2]. Dehydrocorydaline shows strong anti-malarial effects (IC50=38 nM), and low cytotoxicity (cell viability?>?90\%) using P. falciparum 3D7 strain[3].
GLIBORNURIDE
C18H26N2O4S (366.16131960000007)
A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent D007004 - Hypoglycemic Agents
2-{2-benzimidazol-2-yl-1-[(4-methylphenyl)methyl]ethyl}benzimidazole
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.970 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.968 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.963 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.961
Dicarboxyl-2But-A6EO4
Literature spectrum; CONFIDENCE Tentative identification: isomers possible (Level 3); Could be alkyl homologue of given structure; Digitised from figure: approximate intensities
(+)-2-(1-hydroxy-4,4-dimethoxycyclohexyl)ethyl caffeate|2-(1-hydroxy-4,4-dimethoxycyclohexyl)ethyl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate|mairine D
(1alpha,7alpha,14beta)-1,7,14,18,20-pentahydroxy-ent-kaur-16-en-15-one|1alpha,7alpha,14beta,18,20-pentahydroxy-ent-kaur-16-en-15-one|weisiensic C|weisiensin C
(1R,4S,5S,6S,7S,10R)-1-hydroxy-4,15-diacetoxyeudesm-11(13)-en-6,12-olide
methyl (1S,10R,12S,19S)-12-ethenyl-4-hydroxy-9-oxo-8,16-diazapentacyclo[10.6.1.0^{1,10.0^{2,7.0^{16,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate
20-hydroxy-19-methylene-ibogamine-18-carboxylic acid methyl ester|Heyneanin
C22H26N2O3 (366.19433260000005)
[3-(3,7-dimethyl-2,6-octadienyl)-2,4,6-trihydroxyphenyl]phenylmethanone
8alpha-hydroxy-10beta,11alpha-diacetoxyslov-3-enolide
Me glycoside,penta-Me-beta-Pyranose-3-O-beta-D-Xylopyranosyl-D-xylose
6alpha-hydroxyneopulchellin-4-O-<2-methyl butyrate>
3alpha,9beta-diacetoxy-1beta,10-epoxy-germacr-5(4)-en-6beta,12-olide|beibersteneolide-a
rel-(1S,3R,5R,7Z,9R,12S,13S)-9-hydroperoxy-12-hydroxy-16-methylidene-5,9,13-trimethyl-4,14-dioxatricyclo[11.3.2.0(3,5)]octadec-7-en-15-one|snuladiterpene B
(+/-)-trans-3-(4-hydroxy-3-methoxyphenyl)-4-[(E)-3,4-dimethoxystyryl]cyclohex-1-ene
8alpha-isobutyryloxy-11(betaH),13-dihydro-10-epi-tanaparthin-alpha-peroxide
kopsifoline F|methyl (1R,4R,5R,13S,20S)-8-methoxy-6,16-diazahexacyclo[11.6.1.11.4.05.13.07.12.016.20]henicosa-7(12),8,10,18-tetraene-4-carboxylate
C22H26N2O3 (366.19433260000005)
6beta-Hydroxypulchellin 2-O-isovalerate|6beta-hydroxypulchellin-2-O-isovalerate
1beta,6alpha-diacetoxy-4alpha-hydroxyeudesm-11-en-8alpha,12-olide
2-(3,4-dihydroxyphenyl)ethyl [(2,6-dimethoxy-3-ethylidene)tetrahydropyran-4-yl]acetate|3,4-DHPEA-DETA
3,4beta-dihydrosamaderine C|3,4??-Dihydrosamaderine C
Hexa-Me-alpha-Pyranose-2-O-beta-D-Xylopyranosyl-D-xylose
7-oxo-12alpha,13beta,15-trihydroxyabiet-8(14)-en-18-oic acid
(13R,14R)-3,13,14,19-tetrahydroxy-ent-labda-8 (17),11-dien-16,15-olide
19(E)-18-demethoxygardfloramine
A natural product found in Gardneria ovata.
(Z)-4-hydroxy-3-(2-(6-hydroxy-5-(hydroxylmethyl)-5,8a-dimethyloctahydro-1H-spiro[naphthalene-2,2-oxiran]-1-yl)ethylidene)dihydrofuran-2(3H)-one
(E)-(2-(3,7-dimethylocta-2,6-dienyloxy)-4,6-dihydroxyphenyl)(phenyl)methanone|2-geranyloxy-4,6-dihydroxybenzophenone|elegaphenone
(3alpha,6beta,7alpha,8alpha,10alpha,15beta)-7,20-epoxykaur-16-ene-3,6,7,14,15-pentol|rabdonervosin G
15beta-methoxy-14,15-dihydroandranginine
C22H26N2O3 (366.19433260000005)
3,9-diacetoxy-1-hydroxy-6beta,7alpha,11H-germacra-4,10(14)-dien-12,6alpha-olide
(1S,7S)-1,7,17-trihydroxy-15-oxo-ent-kauran-19-oic acid|geopyxin F
(3R,5R)-3-O-beta-D-mannosyl-3,5-dihydrodecanoic acid
7alpha,12alpha,14beta,18,20-pentahydroxy-ent-kaur-16-en-15-one|wikstroemioidin T
10-hydroxyisovallesiachotamine|methyl (2S,12bS)-1,2,6,7,12,12b-hexahydro-9-hydroxy-2-[(2E)-1-oxobut-2-en-2-yl]indolo[2,3-a]quinolizine-3-carboxylate
3alpha,7alpha,11beta,12alpha,14beta-pentahydroxy-ent-kaur-16-en-15-one|wikstroemioidin J
7,8,16,18-Tetrahydroxy-19-serrulatanoic acid|7,8,16,18-tetrahydroxyserrulatan-19-oic acid
3alpha,7alpha,12alpha,14beta,18-pentahydroxy-ent-kaur-16-en-15-one|wikstroemioidin K
11-methoxytabersonine
C22H26N2O3 (366.19433260000005)
The 16-methoxy derivative of tabersonine.
3-[3-hydroxy-4-(3-methylbut-2-enyl)phenyl]-5-(4-hydroxybenzyl)-4-methyldihydrofuran-2(3H)-one
ent-6beta,7beta-epoxy-1-methyl-2,3-didehydro-aspidospermidine-3-carboxylic acid methyl ester|Lochnerinin|N-methyl-lochnericine|N-methyl-tabersonine alpha-epoxide
C22H26N2O3 (366.19433260000005)
(ent-6beta,7alpha)-6,7,9-Trihydroxy-15-oxo-19-kauranoic acid
3,7-dimethyloct-3(10)-ene-1,2,6,7-tetrol 7-O-beta-D-glucopyranoside
4beta,10alpha-dihydroxy-3-oxo-8beta-isobutyroyloxyguaia-11(13)-en-6,12-olide|4beta,10alpha-dihydroxy-3-oxo-8beta-isobutyrylguai-11(13)-en-6alpha,12-olide|7a,10a-dihydroxy-3-oxo-8b-isobutyryloxyguaia-11(13)-en-12,6a-olide|TD-14
(1RS,3SR,5SR,8SR,9RS,13RS)-8,9-dihydroxy-5,9,13-trimethyl-16-methylidene-4,14-dioxatricyclo[11.3.2.0(3,5)]octadecane-12,15-dione|sinulaparvalide A
Methyl glycoside,penta-Me-beta-Pyranose -Xylobiose
7alpha,11beta,12alpha,14beta,20-pentahydroxy-ent-kaur-16-en-15-one|isolushinin J
6,7-seco-16xi,17-dihydroxy-6,7-dioxokaurenoic acid
5-dehydro-3-hydro-7beta-hydroxy-6-oxoeurycolactone E
3,15-Diacetoxyscirpen-4-ol|3,15-diacetoxyscirpenol
9alpha-hydroxy-seco-ratiferolide-5alpha-O-isobutyrate
(19E)-2xi-methoxy-(16alpha)-16,7-dihydro-2H-[1,4]oxazepino[4,5,6:1,2,16]-17-nor-cur-19-en-3-one|Tsilanin|Tsilanine
C22H26N2O3 (366.19433260000005)
12,15-sulfonyl-8(17),13-labdadien-19-oic acid
C20H30O4S (366.18647000000004)
(6S,7R,8S,11S)-8,14-diacetoxy-15-hydroxygermacra-1(10),4-dien-6,12-olide
12,16-Dihydroxystrychnine|3,12-dihydroxystrychnine|4,16-Dihydroxystrychnin
2beta-Hydroxy-2,3,11alpha,13-tetrahydrohelenalin-methacrylat
2-Methyl-2-<4,4-dimethylpent-3-en-yl>-5,7-dihydroxy-6-benzoyl chroman
(2S,6zeta)-3,7-dimethyloct-3(10)-ene-1,2,6,7-tetrol 1-O-beta-D-glucopyranoside|(2S,6?卢)-3,7-Dimethyloct-3(10)-ene-1,2,6,7-tetrol 1-O-??-D-glucopyranoside
8alpha-O-(2,3-dihydroxyisobutyryl)-11beta,13-dihydrodesacylcynaropicrin
(1S,4R,5S,6S,7S,10R)-1,15-diacetoxy-4-hydroxyeudesm-11(13)-en-6,12-olide
1beta-hydroxy-3alpha-(2-methylbutyryloxy)arbusculin A|1beta-hydroxy-3alpha-<2-methylbutyryloxy>arbusculin A
(E)-1-(3-chloro-6-(3,7-dimethylocta-2,6-dienyloxy)-2,4-dihydroxyphenyl)butan-1-one
C20H27ClO4 (366.15977720000006)
16,17-dihydro-16alpha,17-dihydroxy gibberellin A12
Dehydrocorydaline
[C22H24NO4]+ (366.17052440000003)
Annotation level-1 Dehydrocorydaline (13-Methylpalmatine) is an alkaloid that regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP[1]. Dehydrocorydaline elevates p38 MAPK activation. Anti-inflammatory and anti-cancer activities[2]. Dehydrocorydaline shows strong anti-malarial effects (IC50=38 nM), and low cytotoxicity (cell viability?>?90\\%) using P. falciparum 3D7 strain[3]. Dehydrocorydaline (13-Methylpalmatine) is an alkaloid that regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP[1]. Dehydrocorydaline elevates p38 MAPK activation. Anti-inflammatory and anti-cancer activities[2]. Dehydrocorydaline shows strong anti-malarial effects (IC50=38 nM), and low cytotoxicity (cell viability?>?90\%) using P. falciparum 3D7 strain[3].
C20H30O6_2(5H)-Furanone, 5-hydroxy-3-[2-(octahydro-2,3-dihydroxy-5,6,8a-trimethylspiro[naphthalene-1(2H),2-oxiran]-5-yl)ethyl]
C20H30O6_2(5H)-Furanone, 5-hydroxy-4-[2-(octahydro-2,3-dihydroxy-5,6,8a-trimethylspiro[naphthalene-1(2H),2-oxiran]-5-yl)ethyl]
Tobramycin 1-N- or 3-N-carbamoyl, ion source fragment
3-[2-(6,7-dihydroxy-1,2,4a-trimethylspiro[3,4,6,7,8,8a-hexahydro-2H-naphthalene-5,2-oxirane]-1-yl)ethyl]-2-hydroxy-2H-furan-5-one
4-[2-(6,7-dihydroxy-1,2,4a-trimethylspiro[3,4,6,7,8,8a-hexahydro-2H-naphthalene-5,2-oxirane]-1-yl)ethyl]-2-hydroxy-2H-furan-5-one
Anguidin
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins CONFIDENCE Reference Standard (Level 1) D000970 - Antineoplastic Agents
4-[2-(6,7-dihydroxy-1,2,4a-trimethylspiro[3,4,6,7,8,8a-hexahydro-2H-naphthalene-5,2-oxirane]-1-yl)ethyl]-2-hydroxy-2H-furan-5-one_major
3-[2-(6,7-dihydroxy-1,2,4a-trimethylspiro[3,4,6,7,8,8a-hexahydro-2H-naphthalene-5,2-oxirane]-1-yl)ethyl]-2-hydroxy-2H-furan-5-one_major
3-[2-(6,7-dihydroxy-1,2,4a-trimethylspiro[3,4,6,7,8,8a-hexahydro-2H-naphthalene-5,2-oxirane]-1-yl)ethyl]-2-hydroxy-2H-furan-5-one_4.1\\%
4-[2-(6,7-dihydroxy-1,2,4a-trimethylspiro[3,4,6,7,8,8a-hexahydro-2H-naphthalene-5,2-oxirane]-1-yl)ethyl]-2-hydroxy-2H-furan-5-one_minor
Gly Gly His Pro
Gly Gly Pro His
Gly His Gly Pro
Gly His Pro Gly
Gly Pro Gly His
Gly Pro His Gly
Gly Pro Pro Pro
C17H26N4O5 (366.19031060000003)
His Gly Gly Pro
His Gly Pro Gly
His Pro Gly Gly
Pro Gly Gly His
Pro Gly His Gly
Pro Gly Pro Pro
C17H26N4O5 (366.19031060000003)
Pro His Gly Gly
Pro Pro Gly Pro
C17H26N4O5 (366.19031060000003)
Pro Pro Pro Gly
C17H26N4O5 (366.19031060000003)
SKF-96365
C22H26N2O3 (366.19433260000005)
Bufotenine O-glucoside
(2R,6x)-7-Methyl-3-methylene-1,2,6,7-octanetetrol 2-glucoside
Anhydrocinnzeylanol
Sporotrichiol
4-Acetyl-2-prenylphenol glucoside
(1S,2S,4R,8S)-p-Menthane-1,2,8,9-tetrol 2-glucoside
(1R*,2R*,4R*,8S*)-p-Menthane-1,2,8,9-tetrol 9-glucoside
Secoeremopetasitolide A
(S)-ETHYL 2-(((S)-2-OXO-2,3,4,5-TETRAHYDRO-1H-BENZO[B]AZEPIN-3-YL)AMINO)-4-PHENYLBUTANOATE
C22H26N2O3 (366.19433260000005)
1-benzyl-4-(N-propanoylanilino)piperidine-4-carboxylic acid
C22H26N2O3 (366.19433260000005)
Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-cyclopentyl-N-(4-fluorophenyl)- (9CI)
C21H23FN4O (366.18557999999996)
2,2-(2,5-Difluoro-1,4-phenylene)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)
2-BENZYL-1 3-BIS(TERT-BUTOXYCARBONYL)-2&
C18H26N2O4S (366.16131960000007)
1,3-diisocyanato-2-methylbenzene,2-ethyl-2-(hydroxymethyl)propane-1,3-diol,2-methyloxirane
hexanedioic acid,2-(2-hydroxyethoxy)ethanol,oxepan-2-one
(S)-TERT-BUTYL2-(HYDRAZINECARBONYL)PYRROLIDINE-1-CARBOXYLATE
4,5-diisocyanatobicyclo[4.1.0]hepta-1(6),2,4-triene,ethane-1,2-diamine,2-methyloxirane,propane-1,2-diol
C17H26N4O5 (366.19031060000003)
Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-cyclopentyl-N-(2-fluorophenyl)- (9CI)
C21H23FN4O (366.18557999999996)
Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-cyclopentyl-N-(3-fluorophenyl)- (9CI)
C21H23FN4O (366.18557999999996)
Methylatropine nitrate
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics
Thiourea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-[(4-methylphenyl)methyl]-N-propyl- (9CI)
C21H26N4S (366.18780760000004)
Thiourea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-(2-methylpropyl)-N-(phenylmethyl)- (9CI)
C21H26N4S (366.18780760000004)
N-ETHYL-N-PYRIDIN-4-YLMETHYL-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-BENZAMIDE
Trihydridobis(pentaMethylcyclopentadienyl)niobiuM(V)
C20H33Nb+3 (366.16458980000004)
ethyl 3-undecylthieno[3,2-b]thiophene-2-carboxylate
C20H30O2S2 (366.16871199999997)
N-METHYL-N-(2-PYRIDIN-2-YL-ETHYL)-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-BENZAMIDE
Gosogliptin
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
Liafensine
C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor
3-Cinnolinecarboxamide, 4-amino-8-(2,5-dimethoxyphenyl)-N-propyl-
Roluperidone
C22H23FN2O2 (366.17434699999995)
C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
N-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide
1-(5-Oxo-2,3,5,9B-tetrahydro-1H-pyrrolo[2,1-A]isoindol-9-YL)-3-(5-pyrrolidin-2-YL-1H-pyrazol-3-YL)-urea
C19H22N6O2 (366.18041519999997)
Acetamide, 2-((2-hydroxyethyl)thio)-N-(3-(3-(1-piperidinylmethyl)phenoxy)propyl)-
C19H30N2O3S (366.19770300000005)
Urea, 1-(2-hydroxy-3-bornyl)-3-(p-tolylsulfonyl)-, (1R,2R,3S,4S)-
C18H26N2O4S (366.16131960000007)
2-(3,3-dimethyl-1-oxo-4,9-dihydro-2H-xanthen-9-yl)-5,5-dimethylcyclohexane-1,3-dione
L 152804 is an orally active and selective neuropeptide Y Y5 receptor (NPY5-R) antagonist, with a Ki of 26 nM for hY5. L 152804 causes weight loss in diet-induced obese mice by modulating food intake and energy expenditure[1][2].
SKF-96365 free base
C22H26N2O3 (366.19433260000005)
D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
8-(4-aminophenyl)-5-methyl-N-propyl-5H-[1,3]dioxolo[4,5-g]phthalazine-6-carboxamide
SYM2206 is a potent and non-competitive AMPA receptor antagonist, with an IC50 of 1.6 μM. SYM2206 blocks Nav1.6-mediated persistent currents[1][2].
6alpha,9-Difluoro-11beta-hydroxy progesterone
C21H28F2O3 (366.20064019999995)
20,21,21-Trifluoro-3-methoxy-19-nor-17alpha-pregna-1,3,5(10),20-tetraen-17-ol
C21H25F3O2 (366.18065459999997)
4-(6-Cyclohexylmethoxy-9H-purin-2-ylamino)--benzamide
C19H22N6O2 (366.18041519999997)
Rilpivirine
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AG - Non-nucleoside reverse transcriptase inhibitors C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent
3-[2-(2,3-dihydroxy-5,6,8a-trimethyloctahydro-2H-spiro[naphthalene-1,2-oxiran]-5-yl)ethyl]-5-hydroxyfuran-2(5H)-one
[(1R,2R,10R)-10-acetyloxy-4-hydroxy-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2-oxirane]-2-yl]methyl acetate
(1R,2S,3S,4R,8S,9S,12R,13R)-13-hydroxy-13-(hydroxymethyl)-4,8-dimethyltetracyclo[10.2.1.01,9.03,8]pentadecane-2,4-dicarboxylic acid
(1R,2R,5R,6R,8R,9S,10R,11R,12S)-6,12-dihydroxy-6-(hydroxymethyl)-11-methyl-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylic acid
methyl (Z)-2-(3-ethenyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyprop-2-enoate
C22H26N2O3 (366.19433260000005)
methyl (Z)-2-[(3Z)-3-ethylidene-2,4,6,7,12,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate
C22H26N2O3 (366.19433260000005)
(6E,8E,10E,14E)-5,12-dihydroxyicosa-6,8,10,14-tetraenedioic acid
(5E)-5-[5-hydroxy-4-[(E)-3-hydroxyoct-1-enyl]-3-oxo-4,5,6,6a-tetrahydro-3aH-cyclopenta[b]furan-2-ylidene]pentanoic acid
inuchinenolide C
A sesquiterpene lactone that is decahydroazuleno[6,5-b]furan-2(3H)-one substituted by acetyloxy groups at positions 5 and 7, a hydroxy group at position 4, methyl groups at positions 4a and 8 and a methylidene group at position 3. It has been isolated from the aerial parts of Inula hupehensis.
5,5-diethyl-1-[oxo(1-piperidinyl)methyl]-6H-pyrrolo[2,1-a]isoquinoline-2,3-dione
C22H26N2O3 (366.19433260000005)
1-hydroxy-5-nitro-N-(2-phenylethyl)-4-spiro[benzimidazole-2,1-cyclohexane]imine
[2-(3-Fluorophenyl)-5-propyl-pyrazol-3-yl] 2-phenylbutanoate
C22H23FN2O2 (366.17434699999995)
N4-(2-furanylmethyl)-N2-(3-methylphenyl)-6-(4-morpholinyl)-1,3,5-triazine-2,4-diamine
C19H22N6O2 (366.18041519999997)
Methyl (12S,14S,15E)-15-ethylidene-13-(hydroxymethyl)-3-methyl-3,17-diazapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2(10),4,6,8-tetraene-13-carboxylate
C22H26N2O3 (366.19433260000005)
Sarpagan-16-carboxylic acid, 17-hydroxy-1-methyl-, methyl ester, (16R)-
C22H26N2O3 (366.19433260000005)
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(3-methylpiperidin-1-yl)-2-phenylacetamide
C22H26N2O3 (366.19433260000005)
4-(1H-indol-3-yl)butanoic acid [2-(3-methoxyanilino)-2-oxoethyl] ester
4-(1,3-dioxo-2-isoindolyl)-N-[2-(4-methoxyphenyl)ethyl]butanamide
4-(3-Methoxyanilino)-2-methyl-5-oxo-1-phenyl-2-pyrrolecarboxylic acid ethyl ester
methyl (9S,10S,12S,13E,16S,18S)-13-ethylidene-18-hydroxy-8-methyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-17-carboxylate
C22H26N2O3 (366.19433260000005)
(E)-N-cyclohexyl-3-(3,4-dimethoxyphenyl)-N-pyridin-2-ylprop-2-enamide
C22H26N2O3 (366.19433260000005)
(5Z,9S,11R,13E,15S,17Z)-15-hydroperoxy-9,11-epidioxyprosta-5,13,17-trienoic acid
(4-Fluorophenyl)-[4-(4-phenylcyclohexyl)-1-piperazinyl]methanone
4-[3-(1-Naphthalenyl)prop-2-ynyl]-4-(3-phenylprop-2-ynyl)morpholin-4-ium
2-(2-amino-1-benzimidazolyl)-N-(phenylmethyl)-4-quinazolinamine
(1R,2aR,8bR)-1-(hydroxymethyl)-N-propan-2-yl-2-(2-pyridinylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(1R,2aS,8bS)-1-(hydroxymethyl)-N-propan-2-yl-2-(2-pyridinylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(1S,2aR,8bR)-1-(hydroxymethyl)-N-propan-2-yl-2-(2-pyridinylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(1S,2aS,8bS)-1-(hydroxymethyl)-N-propan-2-yl-2-(2-pyridinylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
[(2S,3R)-6-(cyclopropylmethyl)-1-[(4-fluorophenyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-2-yl]methanol
[(3aR,4R,9bR)-4-(hydroxymethyl)-8-[(E)-prop-1-enyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(4-fluorophenyl)methanone
C22H23FN2O2 (366.17434699999995)
(2R,3R,4S)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-1-[4-oxanyl(oxo)methyl]-2-azetidinecarbonitrile
C22H26N2O3 (366.19433260000005)
(2R,3S,4R)-3-[4-(3-cyclopentylprop-1-ynyl)phenyl]-4-(hydroxymethyl)-1-(2-methoxyacetyl)azetidine-2-carbonitrile
C22H26N2O3 (366.19433260000005)
(2S,3S,4R)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-1-[4-oxanyl(oxo)methyl]-2-azetidinecarbonitrile
C22H26N2O3 (366.19433260000005)
(2R,3R,4S)-3-[4-(3-cyclopentylprop-1-ynyl)phenyl]-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2-azetidinecarbonitrile
C22H26N2O3 (366.19433260000005)
(2S,3R,4S)-3-[4-(3-cyclopentylprop-1-ynyl)phenyl]-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2-azetidinecarbonitrile
C22H26N2O3 (366.19433260000005)
(2R,3S,4S)-3-[4-(3-cyclopentylprop-1-ynyl)phenyl]-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2-azetidinecarbonitrile
C22H26N2O3 (366.19433260000005)
(2R,3R,4R)-3-[4-(3-cyclopentylprop-1-ynyl)phenyl]-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2-azetidinecarbonitrile
C22H26N2O3 (366.19433260000005)
N-ethyl-N-[[(2S,3R,4R)-4-(hydroxymethyl)-1-methylsulfonyl-3-phenyl-2-azetidinyl]methyl]cyclopropanecarboxamide
C18H26N2O4S (366.16131960000007)
(2R,3S,4S)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-1-[4-oxanyl(oxo)methyl]-2-azetidinecarbonitrile
C22H26N2O3 (366.19433260000005)
(2S,3S,4S)-3-[4-(3-cyclopentylprop-1-ynyl)phenyl]-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2-azetidinecarbonitrile
C22H26N2O3 (366.19433260000005)
(2S,3S,4R)-3-[4-(3-cyclopentylprop-1-ynyl)phenyl]-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2-azetidinecarbonitrile
C22H26N2O3 (366.19433260000005)
N-ethyl-N-[[(2S,3R,4S)-4-(hydroxymethyl)-1-methylsulfonyl-3-phenyl-2-azetidinyl]methyl]cyclopropanecarboxamide
C18H26N2O4S (366.16131960000007)
N-ethyl-N-[[(2R,3S,4S)-4-(hydroxymethyl)-1-methylsulfonyl-3-phenyl-2-azetidinyl]methyl]cyclopropanecarboxamide
C18H26N2O4S (366.16131960000007)
N-[[(2S,3R,4S)-4-(hydroxymethyl)-3-[4-(5-pyrimidinyl)phenyl]-2-azetidinyl]methyl]cyclopentanecarboxamide
1-[(2S,3R)-2-(hydroxymethyl)-6-[oxo(2-pyrazinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]-1-propanone
1-[(2R,3R)-2-(hydroxymethyl)-3-phenyl-6-(phenylmethyl)-1,6-diazaspiro[3.3]heptan-1-yl]-2-methoxyethanone
C22H26N2O3 (366.19433260000005)
methyl 8-[(2E)-2-[(4-hydroxy-2,6-dimethoxyphenyl)methylidene]hydrazinyl]-8-oxooctanoate
2-(4-benzylpiperazin-1-yl)-N-[(E)-[(Z)-3-(furan-2-yl)-2-methylprop-2-enylidene]amino]acetamide
methyl (1R,16R,18R,21S)-2-methyl-11-oxo-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate
C22H26N2O3 (366.19433260000005)
3-[3-(Ethylamino)-6-ethylimino-2,7-dimethylxanthen-9-yl]propanoic acid
C22H26N2O3 (366.19433260000005)
methyl (1S,9S,14E,16R)-14-ethylidene-2-methyl-18-oxa-2,12-diazahexacyclo[13.3.2.01,9.03,8.09,16.012,19]icosa-3,5,7-triene-16-carboxylate
C22H26N2O3 (366.19433260000005)
1-[[4-[(S)-(3-chlorophenyl)-imidazol-1-ylmethyl]phenyl]methyl]piperazine
(1R,4E,6R,7R,17S)-4-Ethylidene-7,17-dihydroxy-6,7,14-trimethyl-2,9-dioxa-14-azoniatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione
C19H28NO6+ (366.19165280000004)
(2-hydroxy-3-phosphonooxypropyl) (Z)-tridec-9-enoate
[(E)-2-acetamido-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
2-(Phenylethynyl)-2-(para-tolyl)-hexamethyltrisilane
1-(Meta-tolyl)-1,2-bis(trimethylsilyl)-1-silaindene
2-Ethyl-1,1,2,3,3-pentamethyl-4,5-diphenyl-1,2,3-trisilacyclopenta-4-ene
1-(2,2,2-Trimethyl-1-phenyl-1-(o-tolyl)disilanyl)-2-(trimethylsilyl)acetylene
(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-(2-aminoethoxy)-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol
Anguidine
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins D000970 - Antineoplastic Agents
(5R,6Z,8E,14Z)-5-hydroxy-12-oxoicosa-6,8,14-trienedioic acid
Methyl 2-(3-ethenyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyprop-2-enoate
C22H26N2O3 (366.19433260000005)
20-hydroxy-20-oxoleukotriene B4
A member of the class of leukotrienes that is leukotriene B4 in which the terminal methyl group has undergone formal oxidation to the corresponding carboxylic acid.
COTI-2
COTI-2, an anti-cancer agent with low toxicity, is an orally available third generation activator of p53 mutant forms. COTI-2 acts both by reactivating mutant p53 and inhibiting the PI3K/AKT/mTOR pathway. COTI-2 induces apoptosis in multiple human tumor cell lines. COTI-2 exhibits antitumor activity in HNSCC through p53-dependent and -independent mechanisms. COTI-2 converts mutant p53 to wild-type conformation[1][2][3].